Vectura Updates On GSK Litigation

05:55 EDT 13 Sep 2019 | FinanzNachrichten

LONDON (dpa-AFX) - Vectura Group plc (VEC), in an update on GSK Litigation, said the U.S. judge's post-motions ruling further validates Vectura's original decision to pursue action with GSK.The US...

Original Article: Vectura Updates On GSK Litigation


More From BioPortfolio on "Vectura Updates On GSK Litigation"

Quick Search

Relevant Topics

GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...